Literature DB >> 23932243

Transcranial sonography in obsessive-compulsive disorder.

Paraskevi Mavrogiorgou1, Fabio Nalato, Saskia Meves, Stefanie Luksnat, Christine Norra, Ralf Gold, Georg Juckel, Christos Krogias.   

Abstract

There is convergent evidence that basal ganglia structures are involved in the pathogenesis of obsessive-compulsive disorder (OCD). It has been also assumed that OCD is caused by a central serotonergic dysfunction. Transcranial sonography (TCS) has become a reliable, sensitive and non-invasive diagnostic tool concerning the evaluation of extrapyramidal movement disorders. This study used TCS to examine the alterations in different parenchymal regions, especially concerning serotonergic brainstem raphe nuclei as well as basal ganglia in OCD. Thirty-one OCD patients were compared with 31 matched healthy controls. Echogenecities were investigated according to the examination protocol for extrapyramidal disorders using a Siemens Sonoline(®) Elegra system. Obsessive-compulsive disorder patients showed reduced echogenity of the serotonergic brainstem raphe nuclei (32.3%) compared with healthy controls (16.1%). In nine OCD-patients (31%), but only in 2 control subjects (6.2%), a hyperechogenicity of the caudate nucleus was found. Patients with OCD significantly more often reveal a hypoechogenic brainstem raphe possibly reflecting altered serotonergic neurons there and a hyperechogenicity of caudate nucleus indicating structural or molecular cell changes. Further research is warranted to examine, whether TCS is useful in order to classify OCD and its subtypes.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Basal ganglia; OCD; Raphe nuclei; TCS; Ultrasound

Mesh:

Substances:

Year:  2013        PMID: 23932243     DOI: 10.1016/j.jpsychires.2013.07.020

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  3 in total

1.  An unusual gait disorder at the Emergency Department: role of the quantitative assessment of parenchymal transcranial Doppler sonography.

Authors:  Massimiliano Godani; Giuseppe Lanza; Lucia Trevisan; Raffaele Ferri; Rita Bella
Journal:  Quant Imaging Med Surg       Date:  2021-05

2.  Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography.

Authors:  Christos Krogias; Barbara Bellenberg; Christian Prehn; Ruth Schneider; Saskia H Meves; Ralf Gold; Carsten Lukas; Christiane Schneider-Gold
Journal:  J Neurol       Date:  2014-11-11       Impact factor: 4.849

3.  Transcranial midbrain sonography and depressive symptoms in patients with Parkinson's disease.

Authors:  Iva Stanković; Elka Stefanova; Ljubomir Žiropadja; Milija Mijajlović; Aleksandra Pavlović; Vladimir S Kostić
Journal:  J Neurol       Date:  2015-01-04       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.